• News
  • SAN DIEGO
  • Medical

Illumina links with big pharmas on cancer research

San Diego’s Illumina Inc. (Nasdaq: ILMN) announced Thursday that it has formed collaborative partnerships with three leading pharmaceutical companies to develop a universal next-generation genetic sequencing test system for cancers.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
165.22
  -0.22  
- 0.13%
554,429,000
185.00
72.77

Insider Trade Data

Date Insider Shares Type Value
09/24/2014 Henry, Christian O 20,000 Sell $3,345,625
09/24/2014 Henry, Christian O 20,000 Exchange $1,063,800
09/24/2014 Henry, Christian O 20,000 Sell $3,345,625
09/24/2014 Henry, Christian O 20,000 Exchange $1,063,800
09/23/2014 Bowman, Arthur Blaine 5,000 Sell $842,509

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
SIC - 3826 - LABORATORY ANALYTICAL INSTRUMENTS
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
Subscribe Today!